Scripps Research Logo

News Release

Scripps Research Institute Presents Latest on Treatments for Cardiovascular Diseas, Stroke, Alzheimer's, and Arthritis

Free Lecture and Reception 5 pm, Wednesday, April 25 in La Jolla

LA JOLLA, CA, March 28, 2007—Three leading scientists at the Scripps Research Institute will give a free lecture titled "Current Research and Developing New Treatments for Cardiovascular Disease, Stroke, Alzheimer's, and Arthritis—On the Front Lines of Hope," Wednesday evening, April 25 in La Jolla.

Part of the Institute's Frontiers in Science series, the lecture and a reception will begin at 5 pm at Estancia La Jolla Hotel and Spa, 9700 North Torrey Pines Road. Seating is limited. For further information and reservations, contact Ginny Deary, (858) 784-9367, e-mail ginnyd@scripps.edu, by April 16.

Professor John Griffin, Ph.D., of the Department of Molecular and Experimental Medicine, will discuss his investigation of how molecular players like activated protein C contribute to protection against thrombotic diseases, such as ischemic stroke or venous thrombosis, including new therapies that could reduce damage caused by harmful blood clots.

Professor Jeffrey Kelly, Ph.D., of the Department of Chemistry, will talk about developing novel therapeutic strategies using chemistry, biophysical and cell biology approaches to combat Alzheimer's disease.

Professor Martin Lotz, M.D., of the Department of Molecular and Experimental Medicine, will summarize his investigation of rheumatoid arthritis and osteoarthritis to develop novel diagnostic tools and therapeutic approaches. His osteoarthritis research program is focused on mechanisms of joint aging.

The program will be introduced by Douglas A. Bingham, Scripps Research Executive Vice President and Chief Operating Officer.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.


For more information contact:
Office of Communications
10550 North Torrey Pines Road
La Jolla, California 92037

press@scripps.edu